Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanezumab in Japanese adults with chronic low back pain
NCT02725411Phase 3Completed
- Sponsor
- Pfizer
- Start
- May 2016
- Primary completion
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of tanezumab in chronic low back pain (CLBP), sponsored by Pfizer. Started May 2016; status: completed.
02
Drugs
tanezumab
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT02725411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02725411.